USMLE Step 1 & Step 2 CK Complete Study Guide: High-Yield Active Recall Flashcards for Medical Boards

Master USMLE Step 1 and Step 2 CK with 192 board-grade flashcards covering Biochemistry, Immunology, Autonomic Pharmacology, General Pathology, Internal Medicine, and Biostatistics.

Quick Access: Browse All USMLE Flashcard Sets on Flashcards World — 6 complete progressive decks (192 verified flashcards) organized across Basic, Intermediate, and Advanced mastery tiers.

---

1. Complete 6-Deck Progressive Curriculum Matrix (192 Flashcards)

Module	Mastery Level	Curated Flashcard Deck	Cards	Direct Study Link
Module 1	Basic	USMLE Step 1 — Biochemistry, Genetics, Metabolic Pathways & Storage Diseases	32 Cards	Practice Deck →
Module 2	Basic	USMLE Step 1 — Immunology, Hypersensitivity (I–IV), Immunodeficiencies & Transplant	32 Cards	Practice Deck →
Module 3	Intermediate	USMLE Step 1 — Autonomic Pharmacology, Cholinergics, Adrenergics & Toxidromes	32 Cards	Practice Deck →
Module 4	Intermediate	USMLE Step 1 & 2 — General Pathology, Neoplasia, Hemostasis & Oncologic Markers	32 Cards	Practice Deck →
Module 5	Advanced	USMLE Step 2 CK — Internal Medicine, Cardiology, Pulmonology & Nephrology Management	32 Cards	Practice Deck →
Module 6	Advanced	USMLE Step 2 CK — Biostatistics, Epidemiology, Study Design & Medical Ethics	32 Cards	Practice Deck →

---

2. Module-by-Module Syllabus & Sample Active-Recall Flashcards

Each of the 6 modules below is engineered using atomic retrieval prompts: every card isolates a single high-yield rule, diagnostic criterion, statutory article, deadline, or clinical mechanism.

Module 1 (BASIC): USMLE Step 1 — Biochemistry, Genetics, Metabolic Pathways & Storage Diseases

Deck Overview: High-yield enzymes, rate-limiting steps, glycogen/lysosomal storage disorders, inborn errors of metabolism, and inheritance patterns.

• Direct Deck Link: USMLE Step 1 — Biochemistry, Genetics, Metabolic Pathways & Storage Diseases (32 Flashcards)
• Level Filter: Browse all BASIC USMLE Sets

#	Front (Active Recall Prompt)	Back (Verified Exam Answer & Explanation)
1	What is the rate-limiting enzyme of glycolysis, and what are its principal allosteric regulators?	Phosphofructokinase-1 (PFK-1). Activated by AMP and fructose-2,6-bisphosphate (F-2,6-BP); inhibited by ATP and citrate.
2	What enzyme is deficient in classic galactosemia, and how does it clinically present?	Galactose-1-phosphate uridylyltransferase (GALT). Presents in early infancy after milk ingestion with failure to thrive, jaundice, hepatomegaly, infantile cataracts, and increased risk of E. coli sepsis.
3	What is the primary enzyme deficiency and accumulated substrate in Tay-Sachs disease?	Deficiency of Hexosaminidase A leading to GM2 ganglioside accumulation. Characterized by progressive neurodegeneration, cherry-red macular spot, and absence of hepatosplenomegaly (unlike Niemann-Pick).
4	What enzyme deficiency causes Gaucher disease, and what is the characteristic histological finding?	Glucocerebrosidase (beta-glucosidase) deficiency causing glucocerebroside accumulation. Histology shows 'crumpled tissue paper' lipid-laden macrophages.
5	How do you distinguish Niemann-Pick disease from Tay-Sachs disease clinically and enzymatically?	Niemann-Pick has sphingomyelinase deficiency (sphingomyelin accumulation), 'foam cells' on histology, and hepatosplenomegaly alongside the cherry-red macular spot; Tay-Sachs lacks hepatosplenomegaly.
6	What enzyme deficiency causes Fabry disease, and what is its mode of inheritance and classic triad?	Alpha-galactosidase A deficiency (accumulating ceramide trihexoside/Gb3); X-linked recessive. Triad: episodic peripheral neuropathy (acroparesthesias), angiokeratomas, and hypohidrosis; later renal and cardiovascular failure.

Module 2 (BASIC): USMLE Step 1 — Immunology, Hypersensitivity (I–IV), Immunodeficiencies & Transplant

Deck Overview: High-yield immunology: cytokine biology, B and T cell development, HLA associations, Gell and Coombs hypersensitivities, primary immunodeficiencies, and allograft rejection.

• Direct Deck Link: USMLE Step 1 — Immunology, Hypersensitivity (I–IV), Immunodeficiencies & Transplant (32 Flashcards)
• Level Filter: Browse all BASIC USMLE Sets

#	Front (Active Recall Prompt)	Back (Verified Exam Answer & Explanation)
1	What cell surface marker characterizes all mature T lymphocytes, and what markers distinguish helper from cytotoxic T cells?	CD3 is present on all mature T cells as part of the T cell receptor (TCR) complex. Helper T cells express CD4 (binds MHC class II); cytotoxic T cells express CD8 (binds MHC class I).
2	Which major cytokines are secreted by Th1 cells, and what transcription factor regulates Th1 differentiation?	IL-2, IFN-gamma, and TNF-beta (lymphotoxin-alpha); regulated by the transcription factor T-bet. Th1 cells promote cell-mediated immunity and activate macrophages.
3	Which key cytokines are produced by Th2 cells, and what are their specific physiological roles?	IL-4 (induces IgE class switching), IL-5 (eosinophil activation and growth, IgA switching), and IL-13 (mucus production and alternative macrophage activation); driven by GATA-3.
4	What is the immunological mechanism of Type I (immediate) hypersensitivity reactions?	Antigen cross-links preformed specific IgE antibodies bound to high-affinity Fc-epsilon-RI receptors on mast cells and basophils, triggering immediate degranulation of histamine, tryptase, and leukotrienes.
5	What is the immunological mechanism of Type II hypersensitivity, and what are three classic clinical examples?	Antibody (IgG or IgM) directed against fixed cell-surface or tissue antigens, causing complement activation, ADCC, or receptor agonism/antagonism. Examples: Goodpasture syndrome, Myasthenia gravis, and Pemphigus vulgaris.
6	What defines Type III hypersensitivity reactions, and what are classic prototypical conditions?	Deposition of circulating antigen-antibody immune complexes in vascular beds, activating complement and recruiting neutrophils. Examples: Serum sickness, Systemic Lupus Erythematosus (SLE), and Poststreptococcal glomerulonephritis (PSGN).

Module 3 (INTERMEDIATE): USMLE Step 1 — Autonomic Pharmacology, Cholinergics, Adrenergics & Toxidromes

Deck Overview: Receptor signaling (Gq, Gs, Gi), sympathomimetics, sympatholytics, cholinergic agonists/antagonists, and acute toxidrome recognition.

• Direct Deck Link: USMLE Step 1 — Autonomic Pharmacology, Cholinergics, Adrenergics & Toxidromes (32 Flashcards)
• Level Filter: Browse all INTERMEDIATE USMLE Sets

#	Front (Active Recall Prompt)	Back (Verified Exam Answer & Explanation)
1	What G-protein coupled receptor (GPCR) pathway is coupled to alpha-1 adrenergic receptors, and what downstream secondary messengers are produced?	Gq protein. Activates phospholipase C (PLC), which cleaves PIP2 into Inositol 1,4,5-trisphosphate (IP3) and Diacylglycerol (DAG), releasing intracellular Ca2+ and activating Protein Kinase C (PKC).
2	Which autonomic receptors signal via the Gs pathway, and what is the enzymatic cascade?	Beta-1, Beta-2, Beta-3, Dopamine-1 (D1), Histamine-2 (H2), and V2 vasopressin receptors. Gs activates adenylyl cyclase, converting ATP to cyclic AMP (cAMP), which activates Protein Kinase A (PKA).
3	Which autonomic receptors signal via Gi, and what is their biochemical effect?	Alpha-2 adrenergic, Muscarinic M2, and Dopamine-2 (D2) receptors ('MAD 2s'). Gi inhibits adenylyl cyclase, decreasing intracellular cAMP and PKA phosphorylation.
4	What are the physiologic effects of Beta-1 receptor stimulation on the myocardium and the kidney?	In heart: increases chronotropy (HR, SA node), inotropy (contractility), and dromotropy (AV conduction). In kidney: stimulates juxtaglomerular cells to release renin.
5	What are the vascular and bronchodilatory consequences of Beta-2 receptor stimulation?	Stimulates Gs in vascular smooth muscle of skeletal muscle and bronchioles, activating PKA which phosphorylates myosin light chain kinase (MLCK) to inactivate it, producing vasodilation and bronchodilation.
6	What is the mechanism of action and clinical indication for Clonidine and alpha-Methyldopa?	Centrally acting alpha-2 adrenergic agonists in the solitary tract nucleus; decrease central sympathetic outflow, reducing blood pressure and heart rate. Alpha-methyldopa is preferred for gestational hypertension.

Module 4 (INTERMEDIATE): USMLE Step 1 & 2 — General Pathology, Neoplasia, Hemostasis & Oncologic Markers

Deck Overview: Cellular adaptation, cell injury/death, tumor genetics, hallmarks of cancer, coagulation cascades, thrombophilia, and oncologic diagnostic markers.

• Direct Deck Link: USMLE Step 1 & 2 — General Pathology, Neoplasia, Hemostasis & Oncologic Markers (32 Flashcards)
• Level Filter: Browse all INTERMEDIATE USMLE Sets

#	Front (Active Recall Prompt)	Back (Verified Exam Answer & Explanation)
1	What morphological and biochemical features differentiate Apoptosis from Necrosis?	Apoptosis: Programmed, ATP-dependent, cellular shrinkage, intact cell membrane, pyknosis, karyorrhexis, apoptotic bodies, no inflammatory reaction. Necrosis: Unregulated, ATP-depleted, cellular swelling, disrupted membrane, nuclear lysis, marked acute inflammation.
2	What type of necrosis is pathognomonic for ischemic cerebral infarction?	Liquefactive necrosis: Brain tissue hydrolytic enzymes and microglial digestion liquefy dead parenchymal tissue into a cystic cavity, unlike coagulative necrosis seen in solid organs.
3	What is the definition of Dysplasia and how does it differ from Metaplasia?	Metaplasia: Reversible reprogramming of one differentiated adult cell type into another (e.g., Barrett esophagus: squamous to columnar). Dysplasia: Disordered growth with loss of cellular uniformity, architecture, pleomorphism, and hyperchromatic nuclei, considered premalignant.
4	What is the role of p53 in cell cycle arrest and apoptosis, and what syndrome arises from germline TP53 mutations?	p53 arrests the cell cycle at G1/S transition by upregulating p21 (CDK inhibitor) in response to DNA damage, or induces apoptosis via BAX/BAK. Germline TP53 mutation causes Li-Fraumeni syndrome (SBLA: Sarcoma, Breast, Leukemia, Adrenal tumors).
5	What is the function of the Retinoblastoma (Rb) protein at the G1 to S phase checkpoint?	Hypophosphorylated Rb binds and sequesters the E2F transcription factor, blocking transcription of S-phase genes. Cyclin D/CDK4/6 hyperphosphorylates Rb, releasing E2F and driving entry into S phase.
6	What is Knudson's 'two-hit' hypothesis and which tumor suppressor gene served as the classic paradigm?	Both alleles of a tumor suppressor gene must be inactivated for oncogenesis. In hereditary retinoblastoma (RB1 gene on 13q14), one allele is mutated in the germline ('first hit') and a somatic mutation disables the second allele ('second hit').

Module 5 (ADVANCED): USMLE Step 2 CK — Internal Medicine, Cardiology, Pulmonology & Nephrology Management

Deck Overview: Evidence-based clinical guidelines, next best steps in management, acute coronary syndromes, heart failure, pulmonary embolism, ARDS, and acute kidney injury.

• Direct Deck Link: USMLE Step 2 CK — Internal Medicine, Cardiology, Pulmonology & Nephrology Management (32 Flashcards)
• Level Filter: Browse all ADVANCED USMLE Sets

#	Front (Active Recall Prompt)	Back (Verified Exam Answer & Explanation)
1	What is the definitive initial management for acute ST-Elevation Myocardial Infarction (STEMI)?	Emergent Primary Percutaneous Coronary Intervention (PCI) with a door-to-balloon time <90 minutes (or <120 minutes if transferred). If PCI cannot be performed within 120 minutes, administer intravenous fibrinolysis within 30 minutes of arrival.
2	What four drug classes form the guideline-directed medical therapy (GDMT) backbone that reduces mortality in Heart Failure with Reduced Ejection Fraction (HFrEF)?	1. ARNI (Sacubitril-Valsartan) or ACEi/ARB; 2. Beta-blocker (Carvedilol, Metoprolol succinate, or Bisoprolol); 3. Mineralocorticoid receptor antagonist (Spironolactone or Eplerenone); 4. SGLT2 inhibitor (Empagliflozin or Dapagliflozin).
3	What is the initial diagnostic test of choice in a hemodynamically stable patient with high clinical probability for Acute Pulmonary Embolism (PE)?	CT Pulmonary Angiography (CTPA). If renal insufficiency or severe iodinated contrast allergy is present, perform a Ventilation-Perfusion (V/Q) lung scan.
4	What is the immediate management for a hemodynamically UNSTABLE patient (hypotension, SBP <90 mmHg) with massive Acute Pulmonary Embolism?	Intravenous systemic thrombolysis (tissue plasminogen activator, Alteplase/tPA) or catheter-directed embolectomy/surgical thrombectomy if thrombolytic contraindications exist, alongside supportive IV fluids and oxygen/vasopressors.
5	What are the definitive ECG criteria and immediate treatment for Ventricular Fibrillation (VF) or Pulseless Ventricular Tachycardia (pVT)?	Immediate unsynchronized defibrillation (shock) followed by immediate CPR for 2 minutes before rhythm/pulse check; intravenous Epinephrine 1 mg every 3–5 minutes and Amiodarone (300 mg bolus, then 150 mg) for shock-refractory VF/pVT.
6	What is the acute management of stable, symptomatic Paroxysmal Supraventricular Tachycardia (PSVT / AVNRT)?	1. Vagal maneuvers (Valsalva, carotid sinus massage). 2. If unsuccessful, rapid intravenous bolus of Adenosine (6 mg, followed by 12 mg if needed). If patient becomes hemodynamically unstable, perform immediate synchronized cardioversion.

Module 6 (ADVANCED): USMLE Step 2 CK — Biostatistics, Epidemiology, Study Design & Medical Ethics

Deck Overview: Sensitivity, specificity, predictive values, likelihood ratios, odds/hazard ratios, study designs, bias types, phase trials, autonomy, and medical ethics dilemmas.

• Direct Deck Link: USMLE Step 2 CK — Biostatistics, Epidemiology, Study Design & Medical Ethics (32 Flashcards)
• Level Filter: Browse all ADVANCED USMLE Sets

#	Front (Active Recall Prompt)	Back (Verified Exam Answer & Explanation)
1	How are Sensitivity and Specificity defined and calculated from a 2x2 contingency table?	Sensitivity = TP / (TP + FN); the proportion of true disease cases correctly detected by the test. Specificity = TN / (TN + FP); the proportion of non-diseased individuals correctly identified as negative.
2	How does changing disease prevalence affect Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV)?	Sensitivity and Specificity are intrinsic test properties and do NOT change with prevalence. Higher prevalence increases PPV and decreases NPV; lower prevalence decreases PPV and increases NPV.
3	How are Positive Likelihood Ratio (LR+) and Negative Likelihood Ratio (LR-) calculated from sensitivity and specificity?	LR+ = Sensitivity / (1 - Specificity). LR- = (1 - Sensitivity) / Specificity. LR+ > 10 strongly confirms disease; LR- < 0.1 strongly excludes disease, independent of prevalence.
4	How is the Odds Ratio (OR) calculated from a 2x2 table in a Case-Control study?	OR = (a * d) / (b * c), where 'a' = exposed cases, 'b' = exposed controls, 'c' = unexposed cases, and 'd' = unexposed controls. Approximates Relative Risk when disease prevalence is low ('rare disease assumption').
5	How is Relative Risk (RR) calculated from a Cohort study?	RR = Risk in exposed / Risk in unexposed = [a / (a + b)] / [c / (c + d)]. If RR = 1, risk is identical; RR > 1 indicates increased risk; RR < 1 indicates protective association.
6	How is Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) calculated?	ARR = Event rate in control group (CER) - Event rate in treatment group (EER). NNT = 1 / ARR (always rounded UP to the nearest whole integer).

---

3. 8-Week Spaced Repetition & Active Recall Study Schedule

To achieve >90% long-term retention before exam day, follow this structured 8-week interleaving schedule across all 6 decks (192 core cards + your personal error-log cards):

Phase	Target Decks	Daily New Cards	Daily SRS Reviews	Exam Application Protocol
Weeks 1–2 (Foundation)	Module 1 & Module 2 (Basic)	16 cards/day	25–45 reviews	Master core definitions, foundational statutes/physiology, and primary classifications.
Weeks 3–4 (Intermediate Application)	Module 3 & Module 4 (Intermediate)	16 cards/day	50–85 reviews	Interleave Basic & Intermediate decks; drill multi-step clinical vignettes or statutory exceptions.
Weeks 5–6 (Advanced Mastery)	Module 5 & Module 6 (Advanced)	16 cards/day	85–120 reviews	Focus on high-difficulty differentials, numerical deadlines, contraindications, and edge-case traps.
Weeks 7–8 (Final Consolidation)	All 6 USMLE Decks (Interleaved)	0 new cards	100–140 reviews	Full timed mock blocks + rapid spaced-repetition review of flagged/missed cards.

---

4. Direct Links to All Curated Study Decks

• Complete Topic Catalog: USMLE Step 1 & Step 2 CK High-Yield Medical Board Review
• Basic Tier: Basic USMLE Flashcards
• Intermediate Tier: Intermediate USMLE Flashcards
• Advanced Tier: Advanced USMLE Flashcards
• USMLE Step 1 — Biochemistry, Genetics, Metabolic Pathways & Storage Diseases
• USMLE Step 1 — Immunology, Hypersensitivity (I–IV), Immunodeficiencies & Transplant
• USMLE Step 1 — Autonomic Pharmacology, Cholinergics, Adrenergics & Toxidromes
• USMLE Step 1 & 2 — General Pathology, Neoplasia, Hemostasis & Oncologic Markers
• USMLE Step 2 CK — Internal Medicine, Cardiology, Pulmonology & Nephrology Management
• USMLE Step 2 CK — Biostatistics, Epidemiology, Study Design & Medical Ethics